BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23790073)

  • 1. Characterization of monocyte-derived dendritic cells from immunosuppressed renal transplant recipients with and without squamous cell carcinomas.
    Sandvik LF; Volchenkov R; Jonsson R; Appel S
    Scand J Immunol; 2013 Sep; 78(3):291-7. PubMed ID: 23790073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls.
    Sandvik LF; Skarstein K; Krynitz B; Volchenkov R; Sviland L; Leivestad T; Jonsson R; Appel S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2128-35. PubMed ID: 25845701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients.
    Krynitz B; Lundh Rozell B; Lindelöf B
    Acta Derm Venereol; 2010 Jul; 90(4):379-85. PubMed ID: 20574603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD11c(+) dendritic cells rather than Langerhans cells are reduced in normal skin of immunosuppressed renal transplant recipients.
    Sandvik LF; Skarstein K; Sviland L; Svarstad E; Nilsen AE; Leivestad T; Jonsson R; Appel S
    Acta Derm Venereol; 2014 Mar; 94(2):173-8. PubMed ID: 23995623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
    Dziunycz P; Hofbauer GF
    Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of plasmacytoid dendritic cells and type 1 myeloid dendritic cells in peripheral blood of renal transplant recipients with and without squamous cell carcinoma.
    Sandvik LF; Vogelsang P; Leivestad T; Jonsson R; Appel S
    Acta Derm Venereol; 2012 Nov; 92(6):623-4. PubMed ID: 22378032
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.
    Hock BD; Mackenzie KA; Cross NB; Taylor KG; Currie MJ; Robinson BA; Simcock JW; McKenzie JL
    Nephrol Dial Transplant; 2012 Jan; 27(1):402-10. PubMed ID: 21617199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
    Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
    Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
    Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
    J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.
    Gutiérrez-Dalmau A; Revuelta I; Ferrer B; Mascaró JM; Oppenheimer F; Albanell J; Campistol JM
    Transplantation; 2010 Nov; 90(9):986-92. PubMed ID: 20844469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.
    de Graaf YG; Rebel H; Elghalbzouri A; Cramers P; Nellen RG; Willemze R; Bouwes Bavinck JN; de Gruijl FR
    Exp Dermatol; 2008 Apr; 17(4):349-55. PubMed ID: 17979968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients.
    Strobel SB; Safferling K; Lahrmann B; Hoffmann JH; Enk AH; Hadaschik EN; Grabe N; Lonsdorf AS
    Br J Dermatol; 2018 Aug; 179(2):405-412. PubMed ID: 29479687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma.
    Moloney FJ; Kelly PO; Kay EW; Conlon P; Murphy GM
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):674-8. PubMed ID: 15061854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
    Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
    J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
    Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
    Perrem K; Lynch A; Conneely M; Wahlberg H; Murphy G; Leader M; Kay E
    Hum Pathol; 2007 Feb; 38(2):351-8. PubMed ID: 17134737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.